Viewing Study NCT00565656


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-02-26 @ 7:49 PM
Study NCT ID: NCT00565656
Status: TERMINATED
Last Update Posted: 2011-12-08
First Post: 2007-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts
Sponsor: Centre Hospitalier Universitaire de Nice
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module